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Enhancement of adriamycin-induced killing after delayed
plating of plateau-phase V79-cells
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Summary Unfed plateau-phase cultures of Chinese hamster V79-cells were treated for 1 h with various
amounts of adriamycin in the range between 0 and 10 gml-l and subsequently either immediately
trypsinized and plated to assay for survival, or reincubated in medium collected from replicate plateau-phase
cultures and returned to the incubator for various periods of time before plating. Significantly less killing was
observed, for the same adriamycin dose, in cells treated in the plateau-phase and plated immediately
thereafter as compared to cells treated while actively growing. When cell trypsinization and plating was
delayed for up to 22h, a significant increase in killing was observed, and the survival curve obtained
approached that observed after treatment with adriamycin of growing cells. Initially almost expdnential
kinetics were observed for this potentiation of adriamycin-induced cell killing with a t37 of -2h. Cell survival
was still decreasing after 22h of post-treatment incubation in the plateau phase, with no clear indication for
approaching a plateau. However, longer incubations, to establish a plateau, were not possible due to
degeneration of the cultures. Flow cytometry measurements of the intracellular adriamycin content showed
only a small difference between exponentially growing and plateau-phase cells despite the significant
differences in the number of cells per culture at the time of treatment. The rate at which adriamycin-related
fluorescence decayed after adriamycin treatment was slightly higher for cells trypsinized and exposed to fresh
medium than for cells kept in the plateau-phase. The results indicate the importance of the physiological state
and the post-treatment incubation conditions of cells for the final effect of adriamycin on survival.
Much higher doses of adriamycin are usually
required to achieve the same extent of killing in
plateau-phase than in actively growing cell popula-
tions (Barranco, 1975; Barranco & Noval, 1974;
Twentyman & Bleehen, 1975; Sutherland, et al.,
1979; Martin & McNally, 1980; Chambers et al.,
1984). This decrease in the adriamycin killing effect
was partly attributed to the differences pertaining
to the numbers of cells per culture during treatment
in exponentially growing vs. plateau-phase cells,
and it was found to decrease or disappear when cell
survival was plotted against the amount of
adriamycin per cell (Sutherland et al., 1979;
Chambers et al., 1984). Examination of the intra-
cellularly accumulated amount of adriamycin,
however, indicatect a significantly lower killing
effect in plateau-phase cells for similar intracellular
drug accumulation (Chambers et al., 1984),
suggesting that the distinct physiological state of
cells in the plateau-phase may significantly affect
adriamycin-induced cell killing (Barranco 1975;
Twentyman & Bleehen, 1975; Martin & McNally,
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1980). Plateau-phase cultures have been proposed
to be an in vitro model describing a tumour more
closely than actively growing cultures (Hahn &
Little, 1972), and cells at this physiological
condition were found to have increased ability to
repair radiation-induced damage, if a few hours are
allowed to elapse between irradiation and sub-
culture (delayed plating, DP) (Hahn & Little, 1972;
Iliakis & Pohlit, 1979). A similar repair activity was
also observed after irradiation of experimental
tumours in vivo (Hahn et al., 1974).
In this work we report the survival modifications
observed after exposure of plateau-phase cells to
adriamycin followed by either immediate (IP) or
delayed (DP) plating. Delayed-plating protocols
mimic the tumour situation more closely than
immediate-plating protocols since in vivo cells are
not transferred to a 'new' environment after treat-
ment. Contrary to the results obtained under
similar conditions after exposure to ionizing
radiation, delayed plating of cells resulted in a
dramatic potentiation of the adriamycin mediated
killing, and caused plateau-phase cells to respond to
treatment similarly to actively growing cells.
Materials and methods
For the experiments, Chinese hamster V79-cells
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(S171) were used. Details about their origin and
growth conditions have been published (Iliakis,
1985). Briefly, cells grew at 37°C in a humidified
atmosphere of 5% CO2 in MEM supplemented
with 15% foetal calf serum. Cells were subcultured
every 2 days starting at concentrations of 106
cells/25cm2 tissue culture flask (20ml MEM). For
the experiments, cells from these cultures were
plated at a concentration of 4 x 104 cells/dish
(50 mm, 5ml MEM per dish) and were used 4 days
later. At this time, cells had reached a plateau-
phase with more than 80% of the cells (compared
to -30% in growing cell populations) accumulated
in a phase showing a DNA content equivalent to
that of G1 cells (flow cytometry measurements).
The cultures were never refed (unfed plateau-phase
cultures) and the cessation of growth is attributed
to the exhaustion of one or more of the nutrients
from the medium. The pH of the cells in the
plateau-phase of growth was 7.1 +0.1. The
doubling time of the cultures in the exponential
phase was -9h and the concentration reached in
the plateau-phase 6-8 x 106 cells/dish. There was no
cell detachment observed in the cultures at this
state.
Adriamycin (Sigma) was given to the cells from a
lmgml-l water solution and was allowed to act
for 1 h (37°C). After this time period, the medium
was removed from the dishes and cells were rinsed
twice with phosphate buffered saline. Subsequently,
one set was returned to the incubator after addition
of 5ml medium gained from replicate plateau-phase
cultures after filtration to remove viable cells, and
one set was trypsinized and plated. Trypsinization
and plating of the set of cultures that were returned
to pre-treatment conditions were carried out at
various times after treatment depending on the
experimental protocol. The trypsinization was
performed with 0.5% trypsin and 0.2% EDTA for
15min, but it was shortened to 5min (enough to
cause complete detachment of the cells from the
dishes) when flow cytometry measurements of intra-
cellular, adriamycin-related fluorescence were to
follow. Cells were plated to form colonies in two
60 mm tissue culture dishes and were incubated at
37°C for 6-7 days. Twenty-five to 200 colonies were
counted per dish, the standard errors of counting in
the estimation of cell survival thus being between
7% and 14%. Curves were fitted to the data points
by eye. All results reported have been confirmed in
at least two independent experiments.
For the measurements of intracellular adriamycin
concentration, flow cytometry was used (Krishan &
Ganapathi, 1980; Durand & Olive, 1981). It has
been shown that this method gives results similar to
those obtained by fluorimetry (Chambers et al.,
1984). After treatment with adriamycin, and
according to the needs of each particular
experiment, cells were trypsinized or simply
collected by pipetting, and a single cell suspension
was run through a flow cytometer (cyto-
fluorograph, Ortho). Cells were suspended in
PBS and were kept after collection and before
measurement on ice. Excitation of adriamycin was
at 448nm (Spectra Physics laser model 2025-05
operating at 1500mW) and fluorescence emission
was collected at above 550nm using a Schott long
pass filter (OG550). Each measurement resulted in a
histogram storing cells according to their relative
adriamycin related fluorescence in 1024 channels.
The coefficient of variation of these histograms was
between 10-20% and similarly for exponentially
growing and plateau-phase cells. Only a comparison
of the relative fluorescence intensities of cells in
various conditions and physiological states was
attempted, and a calibration reverting these values
to absolute adriamycin concentration was not
performed. The results are shown as mean channel
number for the fluorescence intensity vs. extra-
cellular adriamycin concentration or time.
Results
In Figure 1 (panel A) the survival curves of cells
are shown obtained after exposure to adriamycin of
plateau-phase cells for 1 h. Cells were plated either
immediately after treatment (IP) or after a 22h
incubation under plateau-phase conditions (DP). A
biphasic response was observed for cells plated
immediately after irradiation, the terminal part of
the survival curve showing a Do = 10.8jgml-1. The
shape of the survival curve was found to depend
upon the age of the culture, late plateau-phase
cultures (results not shown) showing essentially a
purely exponential response (with a Do similar to
that observed for the terminal part of the survival
curve (IP) in Figure 1). Plateau-phase cells appear
thus to be significantly more resistant to adriamycin
as compared to actively growing cells, whose
response is shown for comparison in Figure 1 by
the dotted line (Do=0.135jigml-1; results obtained
from Iliakis et al., in preparation), for cells plated
immediately after treatment; delayed plating of
growing cells does not significantly affect survival.
However, a dramatic increase in killing was
observed when the adriamycin treated cells were
returned to plateau-phase conditions for 22h before
plating. The response of cells under these
conditions (Do=0.6jigml-1) approached that of
actively growing cells.
The kinetics of the potentiation of killing
observed after delayed-plating of adriamycin
treated plateau-phase cells are shown in panel B of
Figure 1 for 1h treatment with 4 and 10/jigml-F
adriamycin followed by incubation in the plateau-ADRIAMYCIN IN PLATEAU-PHASE CELLS 247
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phase for up to 24h. Due to degradation of the
treated cultures at later times, longer incubations
were not carried out. The plating efficiency was not
significantly affected (<10% drop) at this time. A
nearly exponential decrease in cell survival was
observed after treatment at either of the concen-
trations used (t37=2h). Although a slower decrease
IP in survival became apparent after 1Oh, a plateau
was not yet reached after 24h of incubation. It is
assumed, therefore, that the effect had not yet
reached its maximum at this point. Similar results
were obtained in three more experiments performed
but some variation was observed in the survival
levels reached after a 20-24h incubation in C-med.
In an attempt to correlate the observed effect on
cell survival with the intracellular adriamycin levels,
actively growing cells (106/dish) were treated with
various amounts of adriamycin, and the
adriamycin-related fluorescence was measured by
flow cytometry. The results obtained are shown in
Figure 2A, where the mean channel N for the
emitted fluorescence is plotted against the
16 20 adriamycin concentration. Depsite the large
differences in the number of cells, the fluorescence
intensities obtained from actively growing and
plateau-phase cells were only slightly different.
ikDR In order to test whether the potentiation of
killing observed after delayed plating of plateau-
ADR phase cells was due to a faster clearance of
adriamycin from the cells subcultured and
incubated in fresh medium after treatment, a set of
dishes was treated for 1 h with 10jugml-
adriamycin. Half of the dishes were returned after
treatment to plateau-phase conditions, whereas the
second half was trypsinized and replated
(3 x 106 cells/dish) in fresh medium. At various times
thereafter, cells were collected and measured for
residual, adriamycin-related fluorescence. The
results obtained are shown in Figure 2B. A slightly
faster decrease of fluorescence was observed for cells
trypsinized and plated in fresh medium after treat-
ment. Three hours after treatment, cells in fresh
medium showed 40% less fluorescence than cells
kept in the plateau-phase, but smaller differences
were observed in other experiments.
24
Discussion
Figure 1 Panel A: Survival curves of cells exposed to
various doses of adriamycin for h in the plateau-
phase of growth, trypsinized and plated either
immediately therafter (IP) or after a 22h incubation in
the plateau-phase (DP). The dotted line shows the
survival curve obtained with actively growing cells.
Panel B: Cell survival as a function of time under
plateau-phase conditions following a 1 h treatment
with the indicated doses ofadriamycin.
The results presented in the previous section indi-
cate that plateau-phase V79-cells are more resistant
to adriamycin than actively growing cells, a result
that cannot be entirely explained by the lower
intracellular drug accumulation observed (Figure 2).
Similar results were also obtained for Chinese
hamster ovary cells (Barranco & Novak, 1974;
Barranco, 1975) and EMT6 cells (Twentyman &
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Figure 2 Panel A: Adriamycin-related fluorescence
intensity given as a mean channel N as a function of
the adriamycin concentration (1 h treatment), for
actively growing (log-phase) and plateau-phase cells.
Panel B: Decay of adriamycin-related fluoresence
intensity following a 1 h treatment with l0igmlPl
adriamycin, in cells that have been kept in plateau-
phase (C-med) or subcultured in fresh medium (F-
med).
Bleehen, 1975; Sutherland et al., 1979). The survival
curves obtained (Figure 1) were biphasic indicating
the presence of subpopulation of cells with differen-
tial sensitivity to adriamycin. Actively or slowly
growing cells present in plateau-phase cultures
might be the sensitive and resting cells the resistant
subpopulations, a hypothesis also supported by the
high sensitivity to adriamycin of growing cells and
the nearly exponential shape of the survival curve of
late - and therefore containing less growing cells -
plateau-phase cultures.
Although no difference in the sensitivity to
adriamycin of exponentially and plateau-phase cells
was found when the results were plotted as survival
vs. amount of adriamycin per cell (Sutherland et al.,
1979; Chambers et al., 1984), plateau-phase cells
were found to be significantly more resistant to
adriamycin than actively growing cells when cell
survival was plotted against intracellularly
measured adriamycin content (Chambers et al.,
1984). In fact, plateau-phase cells were found to
have a higher ability to accumulate adriamycin.
Our results also show similar tendencies, indicating
a higher accumulation of adriamycin by plateau-
phase cells, when plotted against the amount of
adriamycin per 106 cells (see Figure 2 and consider
the cell numbers at the time of the treatment).
These findings suggest that not only the intra-
cellular concentration of adriamycin but also other
physiological-state-dependent factors may modify
the drug cytotoxicity probably by modifying its
interaction with the sensitive target(s).
The potentiation of killing observed after delayed
plating contrasts with observations made under
similar conditions after exposure of mammalian
cells to ionizing radiations (e.g., Han & Little, 1972;
Iliakis & Pohlit, 1979). Although this effect could be
partly explained by the lower rate of intracellular
drug clearance in cells kept in the plateau-phase as
indicated in Figure 2, it is unlikely that this rather
small difference in the clearance rate could entirely
account for such a dramatic potentiation of killing.
It is possible that modifications in the metabolic
state of the cells initiated after their incubation in
fresh medium affect, in a time dependent way, the
pattern of interaction of the sensitive target(s) with
adriamycin, thus, changing the cellular response to
the drug. Furthermore, other factors such as
progression of cells through the cycle, cell-to-cell
contact, drug release from the cells into the medium
and reabsorption by the survivors may result in the
potentiation of killing observed. The influence of
these parameters on the observed potentiation of
killing, as well as the intracellular distribution of
adriamycin in plateau-phase cells incubated in fresh
or conditioned medium are presently under study.
It is not known whether the observed poten-
tiation of adriamycin killing is a phenomenon of
general validity observed in many different systems,
or a peculiarity of the cell line and the conditions
used. Hahn et al. (1979) reported no modification in
cell survival after delayed plating of refed plateau-
phase cultures of Chinese hamster cells, but the
authors do not specify the time interval examined
and the conditions applied; it is possible that refedADRIAMYCIN IN PLATEAU-PHASE CELLS 249
plateau-phase cultures respond somewhat differently
to delayed plating after adriamycin exposure than
unfed plateau-phase cultures. We are presently
investigating this possibility.
The authors are greatly indebted to Professor W. Pohlit,
for his generous support of the present work. Special
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